Case 81

Published on 13/02/2015 by admin

Filed under Cardiovascular

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1188 times

CASE 81

image
image
image

ANSWERS

CASE 81

Hypertrophic Cardiomyopathy

1A and B

2D

3B

4D

References

Harris SR, Glockner J, Misselt AJ, et al. Cardiac MR imaging of nonischemic cardiomyopathies. Magn Reson Imaging Clin N Am. 2008;16(2):165–183.

Soler R, Rodriguez E, Remuinan C, et al. Magnetic resonance imaging of primary cardiomyopathies. J Comput Assist Tomogr. 2003;27(5):724–734.

Cross-Reference

Cardiac Imaging: The REQUISITES, ed 3, pp 53, 284–288.

Comment

Etiology and Clinical Features

HCM is inherited as an autosomal dominant trait with variable penetrance. Patients may be asymptomatic, or they may present with atrial fibrillation, heart failure, syncope, or sudden cardiac death, which is the leading cause of mortality in these patients. Asymmetric hypertrophy of the ventricular septum is the most common distribution, seen in 90% of patients with HCM. Other patterns of hypertrophy are right ventricular, left ventricular, septal, apical, midventricular, and concentric. Patients with heart failure secondary to significant septal hypertrophy and left ventricular outflow obstruction can be treated with septal myectomy or percutaneous transluminal septal myocardial ablation with ethanol.

MRI

MRI can provide anatomic and functional information in HCM and can be most useful when the diagnosis is in question, when invasive therapy is being considered, or when clinical concern requires more thorough assessment than that provided by echocardiography. MRI can be used to identify the distribution of thickened myocardium, to evaluate for systolic anterior motion of the mitral valve, and to calculate left ventricular mass (Fig. A). Late gadolinium enhancement MRI characteristically shows patchy midmyocardial enhancement (Figs. B and C). MRI also can be used for functional evaluation of left ventricular outflow tract obstruction.